Jedin Tablet 150 mg (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
MFDS item code 200000209 · Notified 2000.05.10
This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, prevention of Mendelson syndrome
This medication is effective for conditions such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used for the prevention of post-surgical ulcers and the treatment of gastric and duodenal ulcers caused by NSAID administration. Additionally, it helps improve gastric mucosal lesions in acute gastritis, acute exacerbations of chronic gastritis, and upper gastrointestinal bleeding. It is effective for relief of heartburn or belching symptoms due to excessive gastric acid, and is particularly convenient when taken in liquid form. Overall, this medication is used to improve gastric mucosal damage and regulate gastric acid secretion to enhance digestive health.
(Tablets) 150, 300 mg (Oral solution) 75 mg/sachet Administer 150 mg of ranitidine orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg of this drug orally twice daily, or 300 mg once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same for concurrent therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. Maintenance therapy for gastric and duodenal ulcers: For patients with recurrent ulcers who responded well to short-term therapy with this drug, administer 150 mg once daily at bedtime as maintenance therapy. Reflux esophagitis: Administer 150 mg of this drug twice daily for 8 weeks, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. Zollinger-Ellison syndrome: Initiate treatment with an initial dose of 150 mg of this drug 3 times daily, and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions: Treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this drug twice daily. Premedication for anesthesia (prevention of Mendelson's syndrome): Administer 150 mg of this drug 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis: Administer 150 mg of this drug once daily at bedtime. For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. The dose may be adjusted according to age and symptoms.
Patients 12 years of age and older: For excess stomach acid, heartburn, and acid regurgitation, take 75 mg per dose orally twice daily (liquid formulation only). Ages 8 to 18 years: 150 mg per dose (2 mg per kg of body weight) may be taken up to twice daily.
This medication should not be used in patients with a known allergy to any of its components or those with a history of acute porphyria. It should be used cautiously in patients with impaired kidney function, as the drug may remain in the body longer; thus, dosage reduction or extended dosing intervals is necessary. Caution is also advised for patients with compromised liver function or a history of drug allergies, elderly patients, and those taking NSAIDs. Particularly, patients with gastric ulcers or those over middle age who have newly developed or experienced changes in dyspeptic symptoms should confirm the possibility of gastric cancer before using this medication. This drug should be administered in conjunction with eradication therapy for patients with gastric or duodenal ulcers caused by Helicobacter pylori. Severe allergic reactions, such as anaphylactic shock, may occur rarely; any unusual symptoms should prompt immediate cessation of the medication and consultation with healthcare professionals. Blood tests may reveal abnormalities such as leukopenia and thrombocytopenia; notify a hospital immediately if you experience weakness, bleeding, or fever. The liver function may deteriorate temporarily; if symptoms such as jaundice, fatigue, or loss of appetite occur, stop the medication and consult a physician. Arrhythmias, vasculitis, gastrointestinal symptoms (constipation, nausea, abdominal pain, etc.), and neuropsychiatric symptoms (dizziness, drowsiness, confusion, etc.) may also occur rarely, necessitating caution. This drug has been reported to cause side effects such as gynecomastia, erectile dysfunction, myalgia, and skin rashes, so seek immediate medical advice if you have any unusual symptoms. Elderly patients or those with reduced kidney function may have higher blood drug concentrations, requiring dosage adjustments. While taking this medication, if dizziness or drowsiness occurs, avoid driving or operating hazardous machinery. Interactions with other drugs may occur, so always inform your healthcare provider of any medications you are taking, especially anticoagulants like warfarin, and regularly monitor blood coagulation status when using them concurrently. Women who are pregnant or may become pregnant and breastfeeding mothers should only use this medication after careful consideration when absolutely necessary. The safety for use in children has not been fully established, so special caution is warranted.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent air exposure, at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness and prevents degradation.
White round film-coated tablet
100 tablets (10 tablets/PTP x 10)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.